Keywords: barr, second-quarter, earnings, leap, sales, generic, prozac

Barr second-quarter earnings leap on sales of generic Prozac

Article | 04 February 2002

Print This

Barr Laboratories has reported net earnings of $42.1 million, or $0.91per share, for the second quarter of the fiscal year ended ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in